CIK 0002131524 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Braveheart Bio, Inc.
Sign in to watch- Ticker
- BRVE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 992981994
- Phone
- (415) 707-6312
- Business address
- ONE LETTERMAN DR., BLDG. A, STE. A4-300, SAN FRANCISCO, CA, 94129
- 4 Open-market buy Director bought 83,333 shares at $18.00 ($1,499,994)
- 4 Open-market buy Director bought 4,166 shares at $18.00 ($74,988)
- 4 Open-market buy Chief Development Officer bought 1,111 shares at $18.00 ($19,998)
- 4 Open-market buy CEO and President bought 83,333 shares at $18.00 ($1,499,994)
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 55,555 shares at $18.00 ($999,990)
- 8-K Event Bylaws or fiscal year change
- S-8 Other Securities Offered to Employees in Benefit Plans
- 424B4 Offering Prospectus
- CERT Other Certification
- 3 Insider Initial Statement of Ownership
- EFFECT Other Notice of Effectiveness
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 2 of 3 · 51 filings